• Categories
  • Archives

After 5 Years Cervical Cancer Vaccine Tested in Brazil and US Keeps Working

Young woman gets a cervical cancer vaccine shot

Young woman gets a cervical cancer vaccine shot As the first FDA-approved cancer vaccine, designed to protect against human papillomavirus, has moved from scientific discussion to social debate, other vaccine studies are continuing to make progress. While HPV vaccine efforts had the "benefit" of a viral source for the disease, other researchers are developing vaccines for cancers that are not virally based, in an effort to coax the immune system into attacking cancerous cells.

Today at the 2007 Annual Meeting of the American Association for Cancer Research, presentations on ongoing HPV trials and other new approaches to stimulating the immune system are injecting momentum into cancer vaccine research.

Ongoing evaluation of a phase II trial of a human papillomavirus vaccine, developed to prevent cervical cancer, shows that the vaccine continues to protect against HPV types 16 and 18 at five and a half years into the study, according to researchers from the University of Louisville. Their findings also show that the vaccine offers significant cross-protection for HPV types 45 and 31.

The study follows 1113 women between the ages of 15 and 25 in North America and Brazil randomized to receive three doses of either the vaccine or the control. The vaccine, made by GlaxoSmithKline, which funded the study, is designed to protect against two strains of HPV, types 16 and 18, which together are thought to cause nearly 72 percent of all cases of cervical cancer.

At over five years into the study’s follow-up, the researchers found that approximately 98 percent of subjects still maintained protection against HPV types 16 and 18. Regardless of HPV status, the vaccine also appears to prevent most occurrences of cervical intraepithelial neoplasia lesions – abnormal, precancerous cell growths found in the cervix.

They also found that the vaccination offered significant protection against genetically similar viruses. They determined the vaccine to be 88 percent effective against HPV type 45 and 54 percent effective against HPV type 31.

"Overall, it is not a surprise that the vaccine offers protection against additional types of human papillomavirus, as they are all related genetically," said Stanley Gall, M.D., professor at the University of Louisville. "However, as you get genetically farther from types 16 and 18, you would expect to see less cross-protection."

According to Dr. Gall, effective preventative treatment with the vaccine will depend on the long-term and broad protection the vaccine can offer against cancer-causing HPV types.

Tags:

  • Show Comments (0)

Your email address will not be published. Required fields are marked *

comment *

  • name *

  • email *

  • website *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Ads

You May Also Like

Brazil’s US$ 1 Bi, 700-Mile Ethanol Pipeline in Service in 2009

Brazilian government controlled oil multinational Petrobras president José Sérgio Gabrielli announced that his company ...

Smiles Rewards Program Shared by Brazil’s Varig and Gol Passengers

Starting October 16 customers flying on both Varig and Gol airlines will be able ...

Brazil Takes Its Shoes to Las Vegas Trade Show

Brazilian shoe manufacturers will start in February the activities of the Brazilian Footwear, program ...

Brazil’s State Bank Goes to Argentina Shopping for a Bank to Buy

Brazil's state-owned Banco do Brasil (BB), Latin America's largest government-managed bank, is in talks ...

Brazil Ready to Stay 10 Years in Haiti

Brazilian General Augusto Heleno Ribeiro, commander of the United Nations Peace Forces in Haiti, ...

November 1994

CONTENTS: Cover story: We are reading more (p. 8) All about the president (p. ...

Brazil: In the Backlands, Plump is Beautiful

The cactus dessert is a natural for making people forget things like diets. It ...

International Experts Debate in Brazil Public Radio

Specialists in communication and representatives of major broadcasters in the Americas and Europe have ...

Will US See Brazil-France Alliance as Declaration of War? Brazil Won’t Care

The recently signed agreements between Brazil and France are about much more than the ...

Lula’s Advisor Sees Negotiated Solution for US-Brazil Trade Dispute

In an interview to foreign correspondents, in São Paulo, the special advisor to the ...